Emgality is a monthly subcutaneous injection used to prevent episodic and chronic migraine. Migraine is a condition that causes intense throbbing or pulsating on one side of the head. Migraine may ...
Eli Lilly's (LLY) CGRP antibody Emgality gains a positive view from CHMP for the treatment of migraine in adults, who encounter minimum four migraine spells a month. Eli Lilly and Company LLY ...
Treatment with Emgality reduced monthly migraine headache days by 4.1 days. Eli Lilly has announced that in its recent CONQUER trial, Emgality (galcanezumab-gnlm) met the primary and all key secondary ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する